Published in Infect Immun on August 01, 2000
Pseudomonas fluorescens encodes the Crohn's disease-associated I2 sequence and T-cell superantigen. Infect Immun (2002) 1.31
Molecular machinations: chemokine signals in host-pathogen interactions. Clin Microbiol Rev (2001) 1.07
Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun (2002) 1.01
Apoptotic response of Chang cells to infection with Pseudomonas aeruginosa strains PAK and PAO-I: molecular ordering of the apoptosis signaling cascade and role of type IV pili. Infect Immun (2003) 0.96
Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients. Clin Exp Immunol (2004) 0.93
Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection. Infect Immun (2003) 0.92
Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection. Pediatr Pulmonol (2013) 0.91
The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production. Infect Immun (2006) 0.89
Structure and function of the Type III secretion system of Pseudomonas aeruginosa. Curr Protein Pept Sci (2012) 0.83
Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor kappa B and activator protein 1 in human monocytes. Infect Immun (2003) 0.83
Corr4A and VRT325 do not reduce the inflammatory response to P. aeruginosa in human cystic fibrosis airway epithelial cells. Cell Physiol Biochem (2009) 0.83
Pseudomonas aeruginosa activates Cl- channels in host epithelial cells. Pflugers Arch (2003) 0.78
Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment. BMC Pulm Med (2014) 0.77
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (1990) 17.86
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med (1992) 8.27
Cystic fibrosis. Am J Respir Crit Care Med (1996) 4.56
T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med (1992) 4.31
The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol (1997) 4.07
Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med (1995) 3.47
A new murine CD4+ T cell subset with an unrestricted cytokine profile. J Immunol (1989) 3.43
Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions. Infect Immun (1999) 2.32
The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur J Immunol (1993) 1.92
Functional domains of Pseudomonas aeruginosa exoenzyme S. Infect Immun (1995) 1.68
Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med (1997) 1.63
Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol (1986) 1.60
Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections. Eur J Clin Microbiol (1985) 1.59
A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev (1997) 1.57
Differential activation of cytokine genes in normal CD4-bearing T cells is stimulus dependent. Eur J Immunol (1989) 1.57
Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. Pediatr Pulmonol (1993) 1.51
Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients. Infect Immun (1977) 1.29
Purification of Pseudomonas aeruginosa exoenzyme S. Infect Immun (1987) 1.28
Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Antimicrob Agents Chemother (1994) 1.14
A novel function of IL-12p40 as a chemotactic molecule for macrophages. J Immunol (1999) 1.12
Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR). Clin Exp Immunol (1996) 1.06
Endotoxin and Staphylococcus aureus enterotoxin A induce different patterns of cytokines. Cytokine (1992) 1.06
Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model. J Antimicrob Chemother (1989) 1.00
Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol (1993) 0.94
Both CD4+ and CD8+ human lymphocytes are activated and proliferate in response to Cryptococcus neoformans. Immunology (1997) 0.94
Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect Immun (1995) 0.93
The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10. J Interferon Cytokine Res (1998) 0.92
T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res (1996) 0.92
Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation. J Interferon Cytokine Res (1996) 0.91
Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes. J Immunol Methods (1994) 0.87
Chemokine amplification in mesangial cells. J Immunol (1999) 0.86
Inhaled NO prevents IL-1-induced neutrophil accumulation and associated acute edema in isolated rat lungs. Am J Physiol (1996) 0.82
Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy. J Immunol (1995) 0.81
Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes. Infect Immun (1998) 0.80
Staphylococcal enterotoxins bind H-2Db molecules on macrophages. Proc Natl Acad Sci U S A (1995) 0.80
Recombinant Pseudomonas exoenzyme S and exoenzyme S from Pseudomonas aeruginosa DG1 share the ability to stimulate T lymphocyte proliferation. Can J Microbiol (1999) 0.80
Chemotactic factors in bronchial secretions of cystic fibrosis patients. J Infect Dis (1998) 0.78
Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun (1980) 6.19
Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Bacteriol (1998) 5.34
Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother (1999) 4.29
A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis (1979) 4.27
Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product. Proc Natl Acad Sci U S A (1982) 3.89
Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis (1987) 3.79
Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol (1997) 3.60
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells. J Infect Dis (1981) 3.51
Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients. Infect Immun (1980) 3.23
A Legionella pneumophila gene encoding a species-specific surface protein potentiates initiation of intracellular infection. Infect Immun (1989) 3.18
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis (1988) 3.01
Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun (2001) 2.76
Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun (1982) 2.76
Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol (1999) 2.72
Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells. J Infect Dis (1979) 2.70
Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature (1984) 2.69
Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect (1997) 2.69
Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog (2001) 2.52
The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol (1998) 2.46
Molecular map of the murine S region. Proc Natl Acad Sci U S A (1983) 2.24
Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol (1984) 2.23
A mutation in the mip gene results in an attenuation of Legionella pneumophila virulence. J Infect Dis (1990) 2.01
Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Natl Acad Sci U S A (1983) 1.82
Demonstration of an iron-siderophore-binding protein in the outer membrane of Pseudomonas aeruginosa. Infect Immun (1983) 1.82
Toxins of Pseudomonas aeruginosa: new perspectives. Rev Infect Dis (1983) 1.77
Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun (1994) 1.77
Purification and characterization of the double-stranded DNA-activated protein kinase, DNA-PK, from human placenta. Biochem Cell Biol (1996) 1.75
Broad-host-range cloning and cassette vectors based on the R388 trimethoprim resistance gene. Biotechniques (1996) 1.70
Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase. Infect Immun (1999) 1.70
Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun (1989) 1.70
Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun (1996) 1.70
Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob Agents Chemother (1989) 1.69
Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol (1986) 1.60
Clostridium sordellii infection and toxin neutralization. Pediatr Infect Dis J (1990) 1.53
Ribotype analysis of Pseudomonas pseudomallei isolates. J Clin Microbiol (1993) 1.52
Complete primary structure for the zymogen of human complement factor B. J Biol Chem (1984) 1.48
Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest (1981) 1.40
Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis (1994) 1.38
Pathogenesis of and immunity to melioidosis. Acta Trop (2000) 1.38
Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J Immunol (1994) 1.36
Pseudomonas aeruginosa exoenzyme S is an adhesion. Infect Immun (1991) 1.30
Molecular characterization of genetic loci required for secretion of exoproducts in Burkholderia pseudomallei. J Bacteriol (1999) 1.29
Purification of Pseudomonas aeruginosa exoenzyme S. Infect Immun (1987) 1.28
Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis (1980) 1.28
Syrian hamster female protein: analysis of female protein primary structure and gene expression. Science (1985) 1.28
An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology (2003) 1.27
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother (1999) 1.25
Phylogenetic conservation of a class III major histocompatibility complex antigen, factor B. Isolation and nucleotide sequencing of mouse factor B cDNA clones. J Biol Chem (1983) 1.23
Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J Infect Dis (1985) 1.23
Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS (2000) 1.20
DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex. N Engl J Med (1984) 1.19
Effect of pyochelin on Pseudomonas cepacia respiratory infections. Microb Pathog (1988) 1.18
Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. Am J Respir Crit Care Med (1999) 1.14
Identification and characterization of a two-component regulatory system involved in invasion of eukaryotic cells and heavy-metal resistance in Burkholderia pseudomallei. Infect Immun (1997) 1.14
Characterization of antibody to the ferripyochelin-binding protein of Pseudomonas aeruginosa. Infect Immun (1986) 1.13
Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism. J Clin Invest (1984) 1.13
Three-year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer. Infect Control Hosp Epidemiol (1996) 1.12
The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody. Infect Immun (1999) 1.11
Purification and characterization of a protease from Pseudomonas pseudomallei. Can J Microbiol (1994) 1.07
Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur J Clin Microbiol (1985) 1.07
Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1. Science (1983) 1.02
Lung bacterial clearance in murine pneumococcal pneumonia. Infect Immun (1977) 1.01
Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin Infect Dis (1999) 1.01
Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model. J Antimicrob Chemother (1989) 1.00
Isolation and characterization of the outer-membrane proteins of Burkholderia (Pseudomonas) pseudomallei. Microbiology (1994) 1.00
Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia. J Infect Dis (2000) 1.00
Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro. J Clin Invest (1993) 1.00
The isolation and characterization of cDNA clones for human apolipoprotein CII. J Biol Chem (1984) 0.98
Alveolar epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. Am J Respir Cell Mol Biol (1991) 0.98
The molecular archaeology of a mitochondrial death effector: AIF in Drosophila. Cell Death Differ (2008) 0.98
Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections. J Med Microbiol (1984) 0.97
Immunological cross-reactivity of a Mycoplasma pneumoniae membrane-associated protein antigen with Mycoplasma genitalium and Acholeplasma laidlawii. J Clin Microbiol (1987) 0.97
Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Clin Invest Med (1994) 0.97
Biosynthesis and postsynthetic processing of human C-reactive protein. J Immunol (1983) 0.97
Antibody inhibition of ferripyochelin binding to Pseudomonas aeruginosa cell envelopes. Biochemistry (1984) 0.97
Isolation and sequence analysis of a cDNA clone encoding the fifth complement component. J Biol Chem (1985) 0.96
Monoclonal antibodies to Pseudomonas aeruginosa ferripyochelin-binding protein. Infect Immun (1986) 0.95
Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes. Infect Immun (2000) 0.95
Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med (1999) 0.95
Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol (1993) 0.94
Both CD4+ and CD8+ human lymphocytes are activated and proliferate in response to Cryptococcus neoformans. Immunology (1997) 0.94
Cloning and expression of the Pseudomonas aeruginosa exoenzyme S toxin gene. Microb Pathog (1990) 0.94
Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect Immun (1995) 0.93
Modulatory effect of iron on the pathogenesis of Pseudomonas aeruginosa mouse corneal infections. Infect Immun (1982) 0.93
In vivo-induced genes in Pseudomonas aeruginosa. Infect Immun (2000) 0.92
The mobilization of maternal histone messenger RNA after fertilization of the sea urchin egg. Cell Differ (1978) 0.90
Salicylate potentiates amikacin therapy in rodent models of Klebsiella pneumoniae infection. J Infect Dis (1993) 0.87
Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity. Microbiology (2000) 0.87
LTB4 is present in exudative pleural effusions and contributes actively to neutrophil recruitment in the inflamed pleural space. Clin Exp Immunol (2004) 0.87
Expression of xanthine oxidase activity by murine leukocytes. J Lab Clin Med (1990) 0.86
A factor secreted by a human pulmonary alveolar epithelial-like cell line blocks T-cell proliferation between G1 and S phase. Am J Respir Cell Mol Biol (1992) 0.86
Involvement of the MyD88-independent pathway in controlling the intracellular fate of Burkholderia pseudomallei infection in the mouse macrophage cell line RAW 264.7. Microbiol Immunol (2010) 0.85
Exoenzyme S from Pseudomonas aeruginosa induces apoptosis in T lymphocytes. J Leukoc Biol (2000) 0.84
Factors influencing the adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Rev Infect Dis (1984) 0.84